Reuters logo
BRIEF-Mauna Kea Technologies: multicenter randomized controlled trial shows improved early stomach cancer detection with Cellvizio
August 2, 2017 / 3:57 PM / 2 months ago

BRIEF-Mauna Kea Technologies: multicenter randomized controlled trial shows improved early stomach cancer detection with Cellvizio

Aug 2 (Reuters) - MAUNA KEA TECHNOLOGIES SAS:

* SAYS MULTICENTER RANDOMIZED CONTROLLED TRIAL SHOWS IMPROVED EARLY STOMACH CANCER DETECTION WITH CELLVIZIO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below